Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Capital Employed: 2009-2025

Historic Return on Capital Employed for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to -0.40%.

  • China Pharma Holdings' Return on Capital Employed rose 11.00% to -0.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.40%, marking a year-over-year increase of 11.00%. This contributed to the annual value of -0.43% for FY2024, which is 16.00% down from last year.
  • Per China Pharma Holdings' latest filing, its Return on Capital Employed stood at -0.40% for Q3 2025, which was up 6.17% from -0.42% recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Return on Capital Employed ranged from a high of -0.26% in Q1 2022 and a low of -0.83% during Q4 2022.
  • Over the past 3 years, China Pharma Holdings' median Return on Capital Employed value was -0.42% (recorded in 2025), while the average stood at -0.42%.
  • In the last 5 years, China Pharma Holdings' Return on Capital Employed skyrocketed by 157bps in 2021 and then slumped by 55bps in 2022.
  • China Pharma Holdings' Return on Capital Employed (Quarterly) stood at -0.29% in 2021, then plummeted by 55bps to -0.83% in 2022, then spiked by 53bps to -0.30% in 2023, then decreased by 20bps to -0.50% in 2024, then grew by 11bps to -0.40% in 2025.
  • Its Return on Capital Employed stands at -0.40% for Q3 2025, versus -0.42% for Q2 2025 and -0.47% for Q1 2025.